Concepedia

Publication | Closed Access

Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation Trial

DOI

14

Citations

33

References

2020

Year

Célèste Lebbé, Antoîne Italiano, Nadine Houédé, Ahmad Awada, Philippe Aftimos, Thierry Lesimple, Monica Dinulescu, Jan H.M. Schellens, Suzanne Leijen, Sylvie Rottey,
Targeted Oncology

References

YearCitations

Page 1